The Cooper Companies, Inc. COO CooperSurgical — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Cooper Companies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Cooper Companies, Inc.'s coopersurgical — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Cooper Companies, Inc.'s coopersurgical — cost of sales?
- The Cooper Companies, Inc. (COO) reported coopersurgical — cost of sales of $116.7M in Q1 2026.
- How has The Cooper Companies, Inc.'s coopersurgical — cost of sales changed year-over-year?
- The Cooper Companies, Inc.'s coopersurgical — cost of sales increased by 8.5% year-over-year, from $107.6M to $116.7M.
- What does coopersurgical — cost of sales mean?
- The direct costs incurred to manufacture the products sold by the CooperSurgical segment.
- How do you interpret coopersurgical — cost of sales?
- An increase relative to revenue may indicate rising manufacturing costs or supply chain inefficiencies, while a decrease suggests improved production margins.
- How does coopersurgical — cost of sales compare across companies?
- Standard cost of goods sold (COGS) metric found in all manufacturing and medical device companies.